CASE STUDY
Technical Due Diligence of Private Equity Acquisition
Evaluation of Diagnostic Company's Clinical Chemistry Spin-Out
Commercial Issue
Thinking
Approach
Results
The client, a leading private equity firm, was evaluating acquisition of a target company that was being spun out of a large healthcare company. The client had assembled a due diligence team and required additional technical expertise to evaluate the target company's products, pipeline, and technologies.
The short time-frame we had to conduct our assessment required us to focus on the technical feasibility of the company's product development plans, and its portfolio (test menu).
-
Reviewed company documents provided
-
Attended an on-site visit, including presentations and tours of product development activities
-
Prepared and asked questions to the company, at an on-site visit and subsequently by teleconference calls
-
Developed product development and product performance benchmarks based on our proprietary data and through interviews with external experts
-
Prepared a briefing deck for our client summarizing our findings
-
Participated in a Q&A with the client to address questions related to our findings
-
The client proceeded with the acquisition, which successfully closed at ~$4Bn